# A Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil In the Treatment of Chronic Bronchitis

> **NCT00255983** · PHASE3 · TERMINATED · sponsor: **Replidyne** · enrollment: 491 (actual)

## Conditions studied

- Chronic Bronchitis

## Interventions

- **DRUG:** Faropenem medoxomil
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00255983
- **Lead sponsor:** Replidyne
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-12
- **Primary completion:** 2008-05
- **Final completion:** 2008-06
- **Target enrollment:** 491 (ACTUAL)
- **Why stopped:** financial reasons
- **Last updated:** 2008-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00255983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00255983, "A Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil In the Treatment of Chronic Bronchitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00255983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*